/

Empresas

Sc

No verificado

Scholar Rock

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosMercado de valoresSalud

84 Comunicados de prensa

Ver todos los comunicados de prensa

21/09/2026

Mercado de valores

Finanzas

Biotecnología

Farmacéutica

Salud

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fuente

Editor

1.00

0

11/09/2026

Telefonía

Industria

Ciencia

Farmacéutica

Ir de compras

Infancia

Medicina - Varios

Biotecnología

Higiene alimentaria

Salud

Scholar Rock Announces FDA Approval of ISEMBYLD™ (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA)

Fuente

Editor

1.00

0

02/09/2026

Industria

Sanidad

Ciencia

Farmacéutica

Biotecnología

Medicina - Varios

Material médico sanitario

Higiene alimentaria

Salud

Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral Muscular Dystrophy (FSHD) Program as Participant Dosing Commences in Phase 2 FORGE Trial

Fuente

Editor

1.00

0

27/08/2026

Eventos

Web y redes sociales

Biotecnología

Sanidad

Salud

Farmacéutica

Scholar Rock to Present at Upcoming Investor Conferences

Fuente

Editor

1.00

0

21/08/2026

Industria

Material médico sanitario

Salud

Higiene alimentaria

Biotecnología

Medicina - Varios

Scholar Rock Provides Update on Global Apitegromab Regulatory Progress Across U.S., Europe, and Japan

Fuente

Editor

1.00

0

07/08/2026

Salud

Higiene alimentaria

Sanidad

Medicina - Varios

Farmacéutica

Biotecnología

Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date

Fuente

Editor

1.00

0

06/08/2026

Web y redes sociales

Telefonía

Mercado de valores

Material médico sanitario

Salud

Higiene alimentaria

Biotecnología

Medicina - Varios

Scholar Rock Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Fuente

Editor

1.00

0

29/07/2026

Web y redes sociales

Eventos

Material médico sanitario

Salud

Higiene alimentaria

Biotecnología

Farmacéutica

Scholar Rock to Present at the Canaccord Genuity 46th Annual Growth Conference

Fuente

Editor

1.00

0

20/07/2026

Salud

Higiene alimentaria

Sanidad

Medicina - Varios

Farmacéutica

Biotecnología

Scholar Rock Provides Update on Timing of Committee for Medicinal Products for Human Use (CHMP) Opinion for Apitegromab Marketing Authorisation Application (MAA) for Spinal Muscular Atrophy (SMA)

Fuente

Editor

1.00

0

17/07/2026

Biotecnología

Farmacéutica

Salud

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0